“Assessment	of	a	modified	household	food
weighing	method	in	a	study	of	bone	health	in	China.”	
European	J.	Clin.Nutr. 48	(1994):	442–452. 28
. Potischman	N,	McCulloch	CE,	Byers	T,	et	al. “Breast	cancer	and	dietary
and	plasma	concentrations	of	carotenoids	and	vitamin	A.”	
Am. J.	Clin. Nutr. 52	(1990):	909–915. 29
. Potischman	N,	McCulloch	CE,	Byers	T,	et	al. “Associations	between
breast	cancer,	triglycerides	and	cholesterol.”	
Nutr. Cancer
	15	(1991):
205–215. 30
. Chen	J,	Campbell	TC,	Li	J,	et	al. Diet,	life-style	and	mortality	in	China. A	study	of	the	characteristics	of	65	Chinese	counties
. Oxford,	UK;
Ithaca,	NY;	Beijing,	PRC:	Oxford	University	Press;	Cornell	University
Press;	People’s	Medical	Publishing	House,	1990. 31
. Campbell	TC,	and	Chen	J. “Diet	and	chronic	degenerative
diseases:perspectives	from	China.”	
Am. J.	Clin. Nutr. 59	(Suppl.) (1994):
1153S-1161S. 32
. Campbell	TC. “The	dietary	causes	of	degenerative	diseases:	nutrients	vs
foods.”	
In:
	N.	J.	Temple	and	D.	P.	Burkitt	(eds. ),	
Western	diseases:	their
dietary	prevention	and	reversibility
,	pp. 119–152. Totowa,	NJ:	Humana
Press,	1994. 33
. Campbell	TC,	and	Chen	J. “Diet	and	chronic	degenerative	diseases:	a
summary	of	results	from	an	ecologic	study	in	rural	China.”	
In:
	N.J.
Temple	and	D.	P.	Burkitt	(eds. ),	
Western	diseases:	their	dietary
prevention	and	reversibility
,	pp. 67–118. Totowa,	NJ:	Humana	Press,
1994. 34
. Chittenden	RH. Physiological	economy	in	nutrition
. New	York:	F.A. Stokes,	1904. 35
. Chittenden	RH. The	nutrition	of	man
. New	York:	F.	A.	Stokes,	1907.Chapter	2
1
. Stillings	BR. “World	supplies	of	animal	protein.”	
In
:	J.	W.	G.	Porter	and
B. A.	Rolls	(eds. ),	
Proteins	in	Human	Nutrition
,	pp. 11–33. London:
Academic	Press,	1973. 2
. Campbell	TC,	Warner	RG,	and	Loosli	JK. “Urea	and	biuret	for
ruminants.”	
In
:	Cornell	Nutrition	Conference,	Buffalo,	NY,	1960,	pp. 96–103. 3
. Campbell	TC,	Loosli	JK,	Warner	RG,	et	al. “Utilization	of	biuret	by
ruminants.”	
J. Animal	Science
	22	(1963):	139–145. 4
. Autret	M.	“World	protein	supplies	and	needs. Proceedings	of	the
Sixteenth	Easter	School	in	Agricultural	Science,	University	of
Nottingham,	1969.”	
In
:	R.	A.	Laurie	(ed. ),	
Proteins	in	Human	Food
,	pp. 3–19. Westport,	CT:	Avi	Publishing	Company,	1970. 5
. Scrimshaw	NS,	and	Young	VR. “Nutritional	evaluation	and	the
utilization	of	protein	resources.”	
In:
	C.	E.	Bodwell	(ed. ),	
Evaluation	of
Proteins	for	Humans
,	pp. 1–10. Westport,	CT:	The	Avi	Publishing	Co.,
1976. 6
. Jalil	ME,	and	Tahir	WM. “World	supplies	of	plant	proteins.”	In:	J.	W.	G.
Porter	and	B. A.	Rolls	(eds. ),	
Proteins	in	Human	Nutrition
,	pp. 35–46. London:	Academic	Press,	1973. 7
. Blount	WP. “Turkey	“X”	Disease.”	
Turkeys
	9	(1961):	52,	55–58,	61,	77. 8
. Sargeant	K,	Sheridan	A,	O’Kelly	J,	et	al. “Toxicity	associated	with
certain	samples	of	groundnuts.”	
Nature
	192	(1961):	1096–1097. 9
. Lancaster	MC,	Jenkins	FP,	and	Philp	JM. “Toxicity	associated	with
certain	samples	of	groundnuts.”	
Nature
	192	(1961):	1095–1096. 10
. Wogan	GN,	and	Newberne	PM. “Dose-response	characteristics	of
aflatoxin	B
1
	carcinogenesis	in	the	rat.”	
Cancer
	Res. 27	(1967):	2370–
2376. 11
. Wogan	GN,	Paglialunga	S,	and	Newberne	PM. “Carcinogenic	effects	of
low	dietary	levels	of	aflatoxin	B
1
	in	rats.”	
Food	Cosmet. Toxicol
. 12
(1974):	681–685. 12
. Campbell	TC,	Caedo	JP,	Jr.,	Bulatao-Jayme	J,	et	al. “Aflatoxin	M
1
	in
human	urine.”	
Nature
	227	(1970):	403–404. 13
. Madhavan	TV,	and	Gopalan	C.	“The	effect	of	dietary	protein	on
carcinogenesis	of	aflatoxin.”	
Arch. Path
. 85	(1968):	133–137.Chapter	3
1
. Natural	Resources	Defense	Council. “Intolerable	risk:	pesticides	in	our
children’s	food.”	New	York:	Natural	Resources	Defense	Council,
February	27,	1989. 2
. Winter	C,	Craigmill	A,	and	Stimmann	M.	“Food	Safety	Issues	II. NRDC
report	and	Alar.”	
UC	Davis	Environmental	Toxicology	Newsletter
	9(2)
(1989):	1. 3
. Lieberman	AJ,	and	Kwon	SC. “Fact	versus	fears:	a	review	of	the	greatest
unfounded	health	scares	of	recent	times.”	New	York:	American	Council
on	Science	and	Health,	June,	1998. 4
. Whelan	EM,	and	Stare	FJ. Panic	in	the	pantry:	facts	and	fallacies	about
the	food	you	buy
. Buffalo,	NY:	Prometheus	Books,	1992. 5
. U.S.	Apple	Association. “News	release:	synopsis	of	U.S.	Apple	Press
Conference.”	McLean,	VA:	U.S.	Apple	Association,	February	25,	1999. 6
. Cassens	RG. Nitrite-cured	meat:	a	food	safety	issue	in	perspective
. Trumbull,	CT:	Food	and	Nutrition	Press,	Inc.,	1990. 7
. Lijinsky	W,	and	Epstein	SS. “Nitrosamines	as	environmental
carcinogens.”	
Nature
	225	(1970):	21–23. 8
. National	Toxicology	Program. “Ninth	report	on	carcinogens,	revised
January	2001.”	Washington,	DC:	U.S.	Department	of	Health	and	Human
Services,	Public	Health	Service,	January,	2001. Accessed	at
http://ehis.niehs.nih.gOv/roc/toc9.html#viewe
9
. International	Agency	for	Cancer	Research. IARC	
Monographs	on	the
Evaluation	of	the	Carcinogenic	Risk	of	Chemicals	to	Humans:	Some	N-
Nitroso	Compounds
. Vol. 17	Lyon,	France:	International	Agency	for
Research	on	Cancer,	1978. 10
. Druckrey	H,	Janzowski	R,	and	Preussmann	R.	“Organotrope	carcinogene
wirkungen	bei	65	verschiedenen	N-nitroso-verbindungen	an	BD-ratten.”
Z.	Krebsforsch
. 69	(1967):	103–201. 11
. Thomas	C,	and	So	BT. “Zur	morphologie	der	durch	N-nitroso-
verbindungen	erzeugten	tumoral	im	oberen	verdauungstrakt	der	ratte.”
Arzneimittelforsch
. 19	(1969):	1077–1091. 12
. Eisenbrand	G,	Spiegelhalder	B,	Janzowski	C,	et	al. “Volatile	and	non-
volatile	N-nitroso	compounds	in	foods	and	other	environmental	media.”
IARC	Sci. Publi. 19	(1978):	311–324. 13
. National	Archives	and	Records	Administration. “Code	of	Federal
Regulations:	Title	9,	Animals	and	Animal	Products,	Section	319.180
(9CFR319.180).”	Washington,	DC:	Government	Printing	Office,	2001.14
. Kanfer	S.	October	2,	1972. “The	decline	and	fall	of	the	American	hot
dog.”	
Time:
	86. 15
. Newberne	P.	“Nitrite	promotes	lymphoma	incidence	in	rats.”	
Science
204	(1979):	1079–1081. 16
. Madhavan	TV,	and	Gopalan	C.	“The	effect	of	dietary	protein	on
carcinogenesis	of	aflatoxin.”	
Arch. Path
. 85	(1968):	133–137. 17
. If	this	defect	becomes	part	of	the	first	round	of	daughter	cells,	then	this
will	be	passed	on	to	all	subsequent	generations	of	cells,	with	the
potential	to	eventually	become	clinically	detectable	cancer. However,
this	is	an	oversimplification	of	a	very	complex	process. Perhaps	two	of
the	more	significant	omissions	are	the	hypotheses	that	1)	more	than	one
mutation	may	be	required	to	initiate	and	promote	cancer,	and	2)	not	all
genetic	defects	result	in	cancer. 18
. Mgbodile	MUK,	and	Campbell	TC. “Effect	of	protein	deprivation	of
male	weanling	rats	on	the	kinetics	of	hepatic	microsomal	enzyme
activity.”	
J.	Nutr. 102	(1972):	53–60. 19
. Hayes	JR,	Mgbodile	MUK,	and	Campbell	TC. “Effect	of	protein
deficiency	on	the	inducibility	of	the	hepatic	microsomal	drug-
metabolizing	enzyme	system. I. Effect	on	substrate	interaction	with
cytochrome	P-450.”	
Biochem. Pharmacol
. 22	(1973):	1005–1014. 20
. Mgbodile	MUK,	Hayes	JR,	and	Campbell	TC. “Effect	of	protein
deficiency	on	the	inducibility	of	the	hepatic	microsomal	drug-
metabolizing	enzyme	system. II. Effect	on	enzyme	kinetics	and	electron
transport	system.”	
Biochem. Pharmacol
. 22	(1973):	1125–1132. 21
. Hayes	JR,	and	Campbell	TC. “Effect	of	protein	deficiency	on	the
inducibility	of	the	hepatic	microsomal	drug-metabolizing	enzyme
system. III. Effect	of	3-methylcholanthrene	induction	on	activity	and
binding	kinetics.”	
Biochem. Pharmacol
. 23	(1974):	1721–1732. 22
. Campbell	TC. “Influence	of	nutrition	on	metabolism	of	carcinogens
(Martha	Maso	Honor’s	Thesis).”	
Adv. Nutr. Res. 2	(1979):	29–55. 23
. Preston	RS,	Hayes	JR,	and	Campbell	TC. “The	effect	of	protein
deficiency	on	the	in	vivo	binding	of	aflatoxin	B
1
	to	rat	liver
macromolecules.”	
Life	Sci
. 19	(1976):	1191–1198. 24
. Portman	RS,	Plowman	KM,	and	Campbell	TC. “On	mechanisms
affecting	species	susceptibility	to	aflatoxin.”	
Biochim. Biophys. Acta
	208
(1970):	487–495. 25
. Prince	LO,	and	Campbell	TC. “Effects	of	sex	difference	and	dietary
protein	level	on	the	binding	of	aflatoxin	B
1
	to	rat	liver	chromatin
proteins	in	vivo.”	
Cancer
	Res. 42	(1982):	5053–5059. 26
. Mainigi	KD,	and	Campbell	TC. “Subcellular	distribution	and	covalentbinding	of	aflatoxins	as	functions	of	dietary	manipulation.”	
J	Toxicol. Eviron. Health
	6	(1980):	659–671. 27
. Nerurkar	LS,	Hayes	JR,	and	Campbell	TC. “The	reconstitution	of
hepatic	microsomal	mixed	function	oxidase	activity	with	fractions
derived	from	weanling	rats	fed	different	levels	of	protein.”	
J.	Nutr. 108
(1978):	678–686. 28
. Gurtoo	HL,	and	Campbell	TC. “A	kinetic	approach	to	a	study	of	the
induction	of	rat	liver	microsomal	hydroxylase	after	pretreatment	with
3,4-benzpyrene	and	aflatoxin	B
1
.”	
Biochem. Pharmacol
. 19	(1970):
1729–1735. 29
. Adekunle	AA,	Hayes	JR,	and	Campbell	TC. “Interrelationships	of
dietary	protein	level,	aflatoxin	B
1
	metabolism,	and	hepatic	microsomal
epoxide	hydrase	activity.”	
Life	Sci
. 21	(1977):	1785–1792. 30
. Mainigi	KD,	and	Campbell	TC. “Effects	of	low	dietary	protein	and
dietary	aflatoxin	on	hepatic	glutathione	levels	in	F-344	rats.”	
Toxicol. Appl. Pharmacol
. 59	(1981):	196–203. 31
. Farber	E,	and	Cameron	R.	“The	sequential	analysis	of	cancer
development.”	
Adv. Cancer
	Res. 31	(1980):	125–226. 32
. Foci	response	for	the	various	charts	in	this	chapter	mostly	reflect	“%	of
liver	volume,”	which	integrates	“number	of	foci”	and	“size	of	foci,”	both
of	which	indicate	tumor-forming	tendency. So	that	the	responses	from
individual	experiments	can	be	compared	among	each	other,	the	data	are
adjusted	to	a	common	scale	that	reflects	the	response	produced	by	a
standard	dose	of	aflatoxin	and	by	feeding	a	20%	protein	diet. 33
. Appleton	BS,	and	Campbell	TC. “Inhibition	of	aflatoxin-initiated
preneoplastic	liver	lesions	by	low	dietary	protein.”	
Nutr. Cancer
	3
(1982):	200–206. 34
. Dunaif	GE,	and	Campbell	TC. “Relative	contribution	of	dietary	protein
level	and	Aflatoxin	B
1
	dose	in	generation	of	presumptive	preneoplastic
foci	in	rat	liver.”	J.	
Natl. Cancer	Inst
. 78	(1987):	365–369. 35
. Youngman	LD,	and	Campbell	TC. “High	protein	intake	promotes	the
growth	of	preneoplastic	foci	in	Fischer	#344	rats:	evidence	that	early
remodeled	foci	retain	the	potential	for	future	growth.”	
J.	Nutr. 121
(1991):	1454–1461. 36
. Youngman	LD,	and	Campbell	TC. “Inhibition	of	aflatoxin	Bl-induced
gamma-glutamyl	transpeptidase	positive	(GGT+)	hepatic	preneoplastic
foci	and	tumors	by	low	protein	diets:	evidence	that	altered	GGT+	foci
indicate	neoplastic	potential.”	
Carcinogenesis
	13	(1992):	1607–1613. 37
. Dunaif	GE,	and	Campbell	TC. “Dietary	protein	level	and	aflatoxin	Bl-
induced	preneoplastic	hepatic	lesions	in	the	rat.”	
J.	Nutr. 117	(1987):1298–1302. 38
. Horio	F,	Youngman	LD,	Bell	RC,	et	al. “Thermogenesis,	low-protein
diets,	and	decreased	development	of	AFBl-induced	preneoplastic	foci	in
rat	liver.”	Nutr. Cancer
	16	(1991):	31–41. 39
. About	12%	dietary	protein	is	required	to	maximize	growth	rate,
according	to	the	National	Research	Council	of	the	National	Academy	of
Sciences. 40
. Subcommittee	on	Laboratory	Animal	Nutrition. Nutrient	requirements	of
laboratory	animals. Second	revised	edition,	number	10
. Washington,
DC:	National	Academy	Press,	1972. 41
. National	Research	Council. Recommended	dietary	allowances. Tenth
edition
. Washington,	DC:	National	Academy	Press,	1989. 42
. Schulsinger	DA,	Root	MM,	and	Campbell	TC. “Effect	of	dietary	protein
quality	on	development	of	aflatoxin	Bl-induced	hepatic	preneoplastic
lesions.”	
J.	Natl. Cancer	Inst
. 81	(1989):	1241–1245. 43
. Youngman	LD. The	growth	and	development	of	aflatoxin	Bl-induced
preneoplastic	lesions,	tumors,	metastasis,	and	spontaneous	tumors	as
they	are	influenced	by	dietary	protein	level,	type,	and	intervention
. Ithaca,	NY:	Cornell	University,	Ph.D.	Thesis,	1990. 44
. Beasley	RP. “Hepatitis	B	virus	as	the	etiologic	agent	in	hepatocellular
carcinoma-epidemiologic	considerations.”	
Hepatol. 2
	(1982):	21S-26S. 45
. Blumberg	BS,	Larouze	B,	London	WT,	et	al. “The	relation	of	infection
with	the	hepatitis	B	agent	to	primary	hepatic	carcinoma.”	
Am. J.	Pathol
. 81	(1975):	669–682. 46
. Chisari	FV,	Ferrari	C,	and	Mondelli	MU. “Hepatitis	B	virus	structure	and
biology.”	
Microbiol. Pathol
. 6	(1989):	311–325. 47
. Hu	J,	Cheng	Z,	Chisari	FV,	et	al. “Repression	of	hepatitis	B	virus	(HBV)
transgene	and	HBV-induced	liver	injury	by	low	protein	diet.”	
Oncogene
15	(1997):	2795–2801. 48
. Cheng	Z,	Hu	J,	King	J,	et	al. “Inhibition	of	hepatocellular	carcinoma
development	in	hepatitis	B	virus	transfected	mice	by	low	dietary	casein.”
Hepatology
	26	(1997):	1351–1354. 49
. Hawrylewicz	EJ,	Huang	HH,	Kissane	JQ,	et	al. “Enhancement	of	the
7,12-dimethylbenz(a)a	nthracene	(DMBA)	mammary	tumorigenesis	by
high	dietary	protein	in	rats.”	Nutr. Reps.	Int. 26	(1982):	793–806. 50
. Hawrylewicz	EJ. “Fat-protein	interaction,	defined	2-generation	studies.”
In:	C.	Ip,	D.	E	Birt,	A.	E.	Rogers	and	C.	Mettlin	(eds. ),	
Dietary	fat	and
cancer
,	pp. 403–434. New	York:	Alan	R.	Liss,	Inc.,	1986. 51
. Huang	HH,	Hawrylewicz	EJ,	Kissane	JQ,	et	al. “Effect	of	protein	diet	on
release	of	prolactin	and	ovarian	steroids	in	female	rats.”	
Nutr. Rpts. Int
.26	(1982):	807–820. 52
. O’Connor	TP,	Roebuck	BD,	and	Campbell	TC. “Dietary	intervention
during	the	post-dosing	phase	of	L-azaserine-induced	preneoplastic
lesions.”	
J	Natl	Cancer	Inst
	75	(1985):	955–957. 53
. O’Connor	TP,	Roebuck	BD,	Peterson	F,	et	al. “Effect	of	dietary	intake	of
fish	oil	and	fish	protein	on	the	development	of	L-azaserine-induced
preneoplastic	lesions	in	rat	pancreas.”	
J	Natl	Cancer	Inst
	75	(1985):
959–962. 54
. He	Y. Effects	of	carotenoids	and	dietary	carotenoid	extracts	on	aflatoxin
B
1
-induced	mutagenesis	and	hepatocarcinogenesis
. Ithaca,	NY:	Cornell
University,	PhD	Thesis,	1990. 55
. He	Y,	and	Campbell	TC. “Effects	of	carotenoids	on	aflatoxin	B
1
-induced
mutagenesis	in	S.	typhimurium	TA	100	and	TA	98.”	
Nutr. Cancer
	13
(1990):	243–253.Chapter	4
1
. Li	J-Y,	Liu	B-Q,	Li	G-Y,	et	al. “Atlas	of	cancer	mortality	in	the	People’s
Republic	of	China. An	aid	for	cancer	control	and	research.”	
Int. J.	Epid
. 10	(1981):	127–133. 2
. Higginson	J. “Present	trends	in	cancer	epidemiology.”	
Proc. Can. Cancer	Conf
. 8	(1969):	40–75. 3
. Wynder	EL,	and	Gori	GB. “Contribution	of	the	environment	to	cancer
incidence:	an	epidemiologic	exercise.”	
J.	Natl. Cancer	Inst
. 58	(1977):
825–832. 4
. Doll	R,	and	Peto	R.	“The	causes	of	cancer:	Quantitative	estimates	of
avoidable	risks	of	cancer	in	the	Unites	States	today.”	
J	Natl	Cancer	Inst
66	(1981):	1192–1265. 5
. Fagin	D.	News	release. “Breast	cancer	cause	still	elusive	study:	no	clear
link	between	pollution,	breast	cancer	on	LI.”	August	6,	2002. Newsday.com. Accessed	 at
http://www.newsday.com/news/local/longisland/ny-
licanc062811887aug06.story?coll=ny%2Dtop%2Dheadlines
6
. There	were	82	mortality	rates,	but	about	a	third	of	these	rates	were
duplicates	of	the	same	disease	for	different	aged	people. 7
. Calorie	intake	in	China	is	for	a	65	kg	adult	male	doing	“light	physical
work.”	Comparable	data	for	the	American	male	is	adjusted	for	a	body
weight	of	65	kg. 8
. SerVaas	C.	“Diets	that	protected	against	cancers	in	China.”	
The	Saturday
Evening	Post
	October	1990:	26–28. 9
. All	the	available	disease	mortality	rates	were	arranged	in	a	matrix	so	that
it	was	possible	to	readily	determine	the	relationship	of	each	rate	with
every	other	rate. Each	comparison	was	then	assigned	a	plus	or	minus,
depending	on	whether	they	were	directly	or	inversely	correlated. All	plus
correlations	were	assembled	in	one	list	and	all	minus	correlations	were
assembled	in	a	second	list. Each	individual	entry	in	either	list	was
therefore	positively	related	to	entries	in	its	own	list	but	inversely	related
to	diseases	in	the	opposite	list. Most,	but	not	all,	of	these	correlations
were	statistically	significant. 10
. Campbell	TC,	Chen	J,	Brun	T,	et	al. “China:	from	diseases	of	poverty	to
diseases	of	affluence. Policy	implications	of	the	epidemiological
transition.”	
Ecol. Food	Nutr. 27	(1992):	133–144. 11
. Chen	J,	Campbell	TC,	Li	J,	et	al. Diet,	life-style	and	mortality	in	China. A	study	of	the	characteristics	of	65	Chinese	counties
. Oxford,	UK;Ithaca,	NY;	Beijing,	PRC:	Oxford	University	Press;	Cornell	University
Press;	People’s	Medical	Publishing	House,	1990. 12
. Lipid	Research	Clinics	Program	Epidemiology	Committee. “Plasma
lipid	distributions	in	selected	North	American	Population. The	Lipid
Research	Clinics	Program	Prevalence	Study.”	
Circulation
	60	(1979):
427–439. 13
. Campbell	TC,	Parpia	B,	and	Chen	J. “Diet,	lifestyle,	and	the	etiology	of
coronary	artery	disease:	The	Cornell	China	Study.”	
Am. J.	Cardiol
. 82
(1998):	18T-21T
14
. These	data	are	for	villages	SA,	LC	and	RA	for	women	and	SA,	QC	and
NB	for	men,	as	seen	in	the	monograph	(Chen,	et	al. 1990)
15
. Sirtori	CR,	Noseda	G,	and	Descovich	GC. “Studies	on	the	use	of	a
soybean	protein	diet	for	the	management	of	human
hyperlipoproteinemias.”	
In:
	M.	J.	Gibney	and	D.	Kritchevsky	(eds. ),
Current	Topics	in	Nutrition	and	Disease,	Volume	8:	Animal	and
Vegetable	Proteins	in	Lipid	Metabolism	and	Atherosclerosis
.,	pp. 135–
148. New	York,	NY:	Alan	R.	Liss,	Inc.,	1983. 16
. Carroll	KK. “Dietary	proteins	and	amino	acids—their	effects	on
cholesterol	metabolism.”	In:	M.J.	Gibney	and	D.	Kritchevsky	(eds. ),
Animal	and	Vegetable	Proteins	in	Lipid	Metabolism	and	Atherosclerosis
,
pp. 9–17. New	York,	NY:	Alan	R.	Liss,	Inc.,	1983. 17
. Terpstra	AHM,	Hermus	RJJ,	and	West	CE. “Dietary	protein	and
cholesterol	metabolism	in	rabbits	and	rats.”	In:	M.J.	Gibney	and	D.
Kritchevsky	(eds. ),	
Animal	and	Vegetable	Proteins	in	Lipid	Metabolism
and	Athersclerosis
,	pp. 19–49. New	York:	Alan	R.	Liss,	Inc.,	1983. 18
. Kritchevsky	D,	Tepper	SA,	Czarnecki	SK,	et	al. “Atherogenicity	of
animal	and	vegetable	protein. Influence	of	the	lysine	to	arginine	ratio.”
Atherosclerosis
	41	(1982):	429–431. 19
. Dietary	fat	can	be	expressed	as	percent	of	total	weight	of	the	diet	or	as
percent	of	total	calories. Most	commentators	and	researchers	express	fat
as	percent	of	total	calories	because	we	primarily	consume	food	to	satisfy
our	need	for	calories,	not	our	need	for	weight. I	will	do	the	same
throughout	this	book. 20
. National	Research	Council. Diet,	Nutrition	and	Cancer
. Washington,
DC:	National	Academy	Press,	1982. 21
. United	States	Department	of	Health	and	Human	Services. The	Surgeon
General’s	Report	on	Nutrition	and	Health
. Washington,	DC:
Superintendant	of	Documents,	U.S.	Government	Printing	Office,	1988. 22
. National	Research	Council,	and	Committee	on	Diet	and	Health. Diet	and
health:	implications	for	reducing	chronic	disease	risk
. Washington,	DC:National	Academy	Press,	1989. 23
. Expert	Panel. Food,	nutrition	and	the	prevention	of	cancer,	a	global
perspective
. Washington,	DC:	American	Institute	for	Cancer
Research/World	Cancer	Research	Fund,	1997. 24
. Exceptions	include	those	foods	artificially	stripped	of	their	fat,	such	as
non-fat	milk. 25
. Armstrong	D,	and	Doll	R.	“Environmental	factors	and	cancer	incidence
and	mortality	in	different	countries,	with	special	reference	to	dietary
practices.”	
Int. J. Cancer
	15	(1975):	617–631. 26
. U.S.	Senate. “Dietary	goals	for	the	United	States,	2nd	Edition.”
Washington,	DC:	U.S.	Government	Printing	Office,	1977. 27
. Committee	on	Diet	Nutrition	and	Cancer. Diet,	nutrition	and	cancer:
directions	for	research
. Washington,	DC:	National	Academy	Press,
1983. 28
. There	also	were	a	number	of	other	policy	statements	and	large	human
studies	that	were	begun	at	about	this	time	that	were	to	receive	much
public	discussion	and	that	were	founded	and/or	interpreted	in	relation	to
dietary	fat	and	these	diseases. These	included	the	initiation	of	the	U.S.
Dietary	Guidelines	report	series	begun	in	1980,	the	Harvard	Nurses’
Health	Study	in	1984,	the	initial	reports	of	the	Framingham	Heart	Study
in	the	1960s,	the	Seven	Countries	Study	of	Ancel	Keys,	the	Multiple
Risk	Factor	Intervention	Trial	(MRFIT)	and	others. 29
. Carroll	KK,	Braden	LM,	Bell	JA,	et	al. “Fat	and	cancer.”	
Cancer
	58
(1986):	1818–1825. 30
. Drasar	BS,	and	Irving	D.	“Environmental	factors	and	cancer	of	the	colon
and	breast.”	
Br. J. Cancer
	27	(1973):	167–172. 31
. Haenszel	W,	and	Kurihara	M.	“Studies	of	Japanese	Migrants:	mortality
from	cancer	and	other	disease	among	Japanese	and	the	United	States.”	
J
Natl	Cancer	Inst
	40	(1968):	43–68. 32
. Higginson	J,	and	Muir	CS. “Epidemiology	in	Cancer.”	
In:
	J.	E	Holland
and	E.	Frei	(eds. ),	
Cancer	Medicine
,	pp. 241–306. Philadelphia,	PA:	Lea
and	Febiger,	1973. 33
. The	correlation	of	fat	intake	with	animal	protein	intake	is	84%	for	grams
of	fat	consumed	and	70%	for	fat	as	a	percent	of	calories. 34
. Kelsey	JL,	Gammon	MD,	and	Esther	MJ. “Reproductive	factors	and
breast	cancer.”	
Epidemiol
. Revs. 15	(1993):	36–47. 35
. de	Stavola	BL,	Wang	DY,	Allen	DS,	et	al. “The	association	of	height,
weight,	menstrual	and	reproductive	events	with	breast	cancer:	results
from	two	prospective	studies	on	the	island	of	Guernsey	(United
Kingdom).”	
Cancer	Causes	and	Control
	4	(1993):	331–340.36
. Rautalahti	M,	Albanes	D,	Virtamo	J,	et	al. “Lifetime	menstrual	activity
—indicator	of	breast	cancer	risk.”	(1993):	17–25
37
. It	was	not	possible	to	statistically	detect	an	association	of	blood	hormone
levels	with	breast	cancer	risk	within	this	group	of	women	because	their
blood	samples	were	taken	at	random	times	of	their	menstrual	cycles	and
breast	cancer	rates	were	so	low,	thus	minimizing	the	ability	to	detect
such	an	association,	even	when	real. 38
. Key	TJA,	Chen	J,	Wang	DY,	et	al. “Sex	hormones	in	women	in	rural
China	and	in	Britain.”	
Brit. J. Cancer
	62	(1990):	631–636. 39
. These	biomarkers	include	plasma	copper,	urea	nitrogen,	estradiol,
prolactin,	testosterone	and,	inversely,	sex	hormone	binding	globulin,
each	of	which	has	been	known	to	be	associated	with	animal	protein
intake	from	previous	studies. 40
. For	the	total	dietary	fiber	(TDF),	the	averages	for	China	and	the	U.S.
were	33.3	and	11.1	grams	per	day,	respectively. The	range	of	the	county
averages	are	7.7–77.6	grams	per	day	in	China,	compared	with	a	range	of
2.4–26.6	grams	per	day	for	the	middle	90%	of	American	males. 41
. The	correlation	for	plant	protein	was	+0.53***	and	for	animal	protein
was	+0.12. 42
. In	principle,	using	“cancer	prevalence	within	families”	as	the	outcome
measurement	more	effectively	controls	for	the	various	causes	of	cancer
that	associate	with	different	kinds	of	cancer,	thus	permitting	study	of	an
isolated	effect	of	the	dietary	factor. 43
. Guo	W,	Li	J,	Blot	WJ,	et	al. “Correlations	of	dietary	intake	and	blood
nutrient	levels	with	esophageal	cancer	mortality	in	China.”	
Nutr. Cancer
13	(1990):	121–127. 44
. The	full	effects	of	these	fat-soluble	antioxidants	can	be	demonstrated
only	when	antioxidant	concentrations	are	adjusted	for	the	levels	of	LDL
for	individual	subjects. This	was	not	known	at	the	time	of	the	survey,
thus	provisions	were	not	made	for	this	adjustment. 45
. Kneller	RW,	Guo	W,	Hsing	AW,	et	al. “Risk	factors	for	stomach	cancer
in	sixty-five	Chinese	counties.”	
Cancer	Epi. Biomarkers	Prev
. 1	(1992):
113–118. 46
. Information	Plus. Nutrition:	a	key	to	good	health
. Wylie,	TX:
Information	Plus,	1999. 47
. Westman	EC,	Yancy	WS,	Edman	JS,	et	al. “Carbohydrate	Diet
Program.”	
Am. J.	Med
. 113	(2002):	30–36. 48
. Atkins	RC. Dr.	Atkins’	New	Diet	Revolution
. New	York,	NY:	Avon
Books,	1999. 49
. Wright	JD,	Kennedy-Stephenson	J,	Wang	CY,	et	al. “Trends	in	Intake	ofEnergy	and	Macronutrients—United	States,	1971–2000.”	
Morbidity	and
mortality	weekly	report
	53	(February	6,	2004):	80–82. 50
. Noakes	M,	and	Clifton	PM. “Weight	loss	and	plasma	lipids.”	
Curr. Opin. Lipidol
. 11	(2000):	65–70. 51
. Bilsborough	SA,	and	Crowe	TC. “Low-carbohydrate	diets:	what	are	the
potential	short-	and	long-term	health	implications?”	
Asia	Pac. J.	Clin. Nutr. 12	(2003):	396–404. 52
. Stevens	A,	Robinson	DP,	Turpin	J,	et	al. “Sudden	cardiac	death	of	an
adolescent	during	dieting.”	
South. Med. J
. 95	(2002):	1047–1049. 53
. Patty	A. “Low-carb	fad	claims	teen’s	life	-	Star	diet	blamed	in	death.”
The	Daily	Telegraph	(Sidney,	Australia)
	November	2,	2002:	10. 54
. Atkins,	1999. Page	275. 55
. Atkins	claims	that	an	antioxidant	cocktail	can	protect	against	heart
disease,	cancer	and	aging,	a	claim	refuted	by	several	large	trials	recently
completed	(see	chapter	11). 56
. Atkins,	1999. Page	103. 57
. Bone	J. “Diet	doctor	Atkins	‘obese’,	had	heart	problems:	coroner:
Widow	angrily	denies	that	opponents’	claims	that	heart	condition	caused
by	controverial	diet.”	
Ottawa	Citizen
	February	11,	2004:	All. 58
. Campbell	TC. “Energy	balance:	interpretation	of	data	from	rural	China.”
Toxicological	Sciences
	52	(1999):	87–94. 59
. Horio	F,	Youngman	LD,	Bell	RC,	et	al. “Thermogenesis,	low-protein
diets,	and	decreased	development	of	AFBl-induced	preneoplastic	foci	in
rat	liver.”	
Nutr. Cancer
	16	(1991):	31–41. 60
. Krieger	E,	Youngman	LD,	and	Campbell	TC. “The	modulation	of
aflatoxin(AFBl)	induced	preneoplastic	lesions	by	dietary	protein	and
voluntary	exercise	in	Fischer	344	rats.”	
FASEB	J. 2	(1988):	3304	Abs. 61
. The	cited	associations	of	total	animal	and	plant	protein	intakes	are	taken
from	manuscript	under	review
62
. Campbell	TC,	Chen	J,	Liu	C,	et	al. “Non-association	of	aflatoxin	with
primary	liver	cancer	in	a	cross-sectional	ecologic	survey	in	the	People’s
Republic	of	China.”	
Cancer	Res. 50	(1990):	6882–6893.PART	IIChapter	5
1
. Adams	CE	“How	many	times	does	your	heart	beat	per	year?”	Accessed
October	 20,	 2003. Accessed	 at
http://www.straightdope.com/classics/al_088a.html
2
. National	Heart,	Lung,	and	Blood	Institute. “Morbidity	and	Mortality:
2002	Chart	Book	on	Cardiovascular,	Lung,	and	Blood	Diseases.”
Bethesda,	MD:	National	Institutes	of	Health,	2002. 3
. American	Heart	Association. “Heart	Disease	and	Stroke	Statistics-2003
Update.”	Dallas,	TX:	American	Heart	Association,	2002. 4
. Braunwald	E.	“Shattuck	lecture-cardiovascular	medicine	at	the	turn	of
the	millenium:	triumphs,	concerns	and	opportunities.”	
New	Engl. J.	Med
. 337	(1997):	1360–1369. 5
. American	Cancer	Society. “Cancer	Facts	and	Figures-1998.”	Atlanta,
GA:	American	Cancer	Society,	1998. 6
. Anderson	RN. “Deaths:	leading	causes	for	2000.”	
National	Vital
Statistics	Reports
	50(16)	(2002):
7
. Enos	WE,	Holmes	RH,	and	Beyer	J. “Coronary	disease	among	United
States	soldiers	killed	in	action	in	Korea.”	JAMA	152	(1953):	1090–1093. 8
. Esselstyn	CJ. “Resolving	the	coronary	artery	disease	epidemic	through
plant-based	nutrition.”	
Prev. Cardiol
. 4	(2001):	171–177. 9
. Antman	EM,	and	Braunwald	E.	“Acute	myocardial	infarction.”	
In:
	E.
Braunwald	(ed. ),	
Heart	disease,	a	textbook	of	cardiovascular	disease
,
Vol. II	(Fifth	Edition),	pp. 1184–1288. Philadelphia:	W.B. Saunders
Company,	1997. 10
. Esselstyn	CJ. “Lecture:	Reversing	heart	disease.”	December	5,	2002. Ithaca,	NY:	Cornell	University,	2002. 11
. Ambrose	JA,	and	Fuster	V.	“Can	we	predict	future	acute	coronary	events
in	patients	with	stable	coronary	artery	disease?”	
JAMA
	277	(1997):	343–
344. 12
. Forrester	JS,	and	Shah	PK. “Lipid	lowering	versus	revascularization:	an
idea	whose	time	(for	testing)	has	come.”	
Circulation
	96	(1997):	1360–
1362. 13
. Now	named	the	National	Heart,	Lung,	and	Blood	Institute	of	the
National	Institutes	of	Health	in	Bethesda,	Maryland. 14
. Gofman	JW,	Lindgren	F,	Elliot	H,	et	al. “The	role	of	lipids	and
lipoproteins	in	atherosclerosis.”	
Science
	111	(1950):	166. 15
. Kannel	WB,	Dawber	TR,	Kagan	A,	et	al. “Factors	of	risk	in	the
development	of	coronary	heart	disease—six-year	follow-up	experience.”Ann. Internal	Medi
. 55	(1961):	33–50. 16
. Jolliffe	N,	and	Archer	M.	“Statistical	associations	between	international
coronary	heart	disease	death	rates	and	certain	environmental	factors.”	
J. Chronic	Dis
. 9	(1959):	636–652. 17
. Scrimgeour	EM,	McCall	MG,	Smith	DE,	et	al. “Levels	of	serum
cholesterol,	triglyceride,	HDL	cholesterol,	apolipoproteins	A-l	and	B,
and	plasma	glucose,	and	prevalence	of	diastolic	hypertension	and
cigarette	smoking	in	Papua	New	Guinea	Highlanders.”	
Pathology
	21
(1989):	46–50. 18
. Campbell	TC,	Parpia	B,	and	Chen	J. “Diet,	lifestyle,	and	the	etiology	of
coronary	artery	disease:	The	Cornell	China	Study.”	
Am. J.	Cardiol
. 82
(1998):	18T-21T. 19
. Kagan	A,	Harris	BR,	Winkelstein	W,	et	al. “Epidemiologic	studies	of
coronary	heart	disease	and	stroke	in	Japanese	men	living	in	Japan,
Hawaii	and	California.”	
J. Chronic	Dis
. 27	(1974):	345–364. 20
. Kato	H,	Tillotson	J,	Nichaman	MZ,	et	al. “Epidemiologic	studies	of
coronary	heart	disease	and	stroke	in	Japanese	men	living	in	Japan,
Hawaii	and	California:	serum	lipids	and	diet.”	
Am. J.	Epidemiol
. 97
(1973):	372–385. 21
. Morrison	LM. “Arteriosclerosis.”	
JAMA
	145	(1951):	1232–1236. 22
. Morrison	LM. “Diet	in	coronary	atherosclerosis.”	
JAMA
	173	(1960):
884–888. 23
. Lyon	TP,	Yankley	A,	Gofman	JW,	et	al. “Lipoproteins	and	diet	in
coronary	heart	disease.”	
California	Med
. 84	(1956):	325–328. 24
. Gibney	MJ,	and	Kritchevsky	D,	eds. Current	Topics	in	Nutrition	and
Disease,	Volume	8:	Animal	and	Vegetable	Proteins	in	Lipid	Metabolism
and	Atherosclerosis
. New	York,	NY:	Alan	R.	Liss,	Inc.,	1983. 25
. Sirtori	CR,	Noseda	G,	and	Descovich	GC. “Studies	on	the	use	of	a
soybean	protein	diet	for	the	management	of	human
hyperlipoproteinemias.”	In:	M.	J.	Gibney	and	D.	Kritchevsky	(eds. ),
Current	Topics	in	Nutrition	and	Disease,	Volume	8:	Animal	and
Vegetable	Proteins	in	Lipid	Metabolism	and	Atherosclerosis
.,	pp. 135–
148. New	York,	NY:	Alan	R.	Liss,	Inc.,	1983. 26
. G.S. Myers,	personal	communication,	cited	by	Groom,	D.	“Population
studies	of	atherosclerosis.”	Ann. Internal	Med. 55(1961):51–62. 27
. Centers	for	Disease	Control. “Smoking	and	Health:	a	national	status
report.”	
Morbidity	and	Mortality	Weekly	Report
	35	(1986):	709–711. 28
. Centers	for	Disease	Control. “Cigarette	smoking	among	adults—United
States,	2000.”	
Morbidity	and	Mortality	Weekly	Report
	51	(2002):	642–
645.29
. Age-adjusted,	ages	25–74. 30
. Marwick	C.	“Coronary	bypass	grafting	economics,	including
rehabilitation. Commentary.”	
Curr. Opin. Cardiol
. 9	(1994):	635–640. 31
. Page	1319	in	Gersh	BJ,	Braunwald	E,	and	Rutherford	JD. “Chronic
coronary	artery	disease.”	In:	E.	Braunwald	(ed. ),	Heart	Disease:	A
Textbook	of	cardiovascular	Medicine,	Vol. 2(Fifth	Edition),	pp. 1289–
1365. Philadelphia,	PA:	W.B. Saunders,	1997. 32
. Ornish	D.	“Avoiding	revascularization	with	lifestyle	changes:	the
Multicenter	Lifestyle	Demonstration	Project.”	
Am. J.	Cardiol
. 82	(1998):
72T-76T
33
. Shaw	PJ,	Bates	D,	Cartlidge	NEF,	et	al. “Early	intellectual	dysfunction
following	coronary	bypass	surgery.”	
Quarterly	J.	Med
. 58	(1986):	59–
68. 34
. Cameron	AAC,	Davis	KB,	and	Rogers	WJ. “Recurrence	of	angina	after
coronary	artery	bypass	surgery. Predictors	and	prognosis	(CASS
registry).”	
J. Am. Coll. Cardiol
. 26	(1995):	895–899. 35
. Page	1320	in	Gersh	BJ,	Braunwald	E,	and	Rutherford	JD. “Chronic
coronary	artery	disease.”	In:	E.	Braunwald	(ed. ),	Heart	Disease:	A
Textbook	of	cardiovascular	Medicine,	Vol. 2(Fifth	Edition),	pp. 1289–
1365. Philadelphia,	PA:	W.B. Saunders,	1997. 36
. Kirklin	JW,	Naftel	DC,	Blackstone	EH,	et	al. “Summary	of	a	consensus
concerning	death	and	ischemic	events	after	coronary	artery	bypass
grafting.”	
Circulation
	79(Suppl	1)	(1989):	181–191. 37
. Page	1368–9	in	Lincoff	AM,	and	Topol	EJ. “Interventional	catherization
techniques.”	In:	E.	
Braunwald	(ed. ),	Heart	Disease:	A	Textbook	of
Cardiovascular	Medicine,	pp. 1366–1391. Philadelphia,	PA:	W.B. Saunders,	1997. 38
. Hirshfeld	JW,	Schwartz	JS,	Jugo	R,	et	al. “Restenosis	after	coronary
angioplasty:	a	multivariate	statistical	model	to	relate	lesion	and
procedure	variables	to	restenosis.”	
J. Am. Coll. Cardiol
. 18	(1991):	647–
656. 39
. Information	Plus. Nutrition:	a	key	to	good	health
. Wylie,	TX:
Information	Plus,	1999. 40
. Naifeh	SW. The	Best	Doctors	in	America,	1994–1995
. Aiken,	S.C.:
Woodward	&	White,	1994. 41
. Esselstyn	CB,	Jr.	“Foreward:	changing	the	treatment	paradigm	for
coronary	artery	disease.”	
Am. J.	Cardiol
. 82	(1998):	2T-4T
42
. Esselstyn	CB,	Ellis	SG,	Medendorp	SV,	et	al. “A	strategy	to	arrest	and
reverse	coronary	artery	disease:	a	5-year	longitudinal	study	of	a	single
physician’s	practice.”	
J. Family	Practice
	41	(1995):	560–568.43
. Esselstyn	CJ. “Introduction:more	than	coronary	artery	disease.”	
Am. J.
Cardiol
. 82	(1998):	5T-9T. 44
. The	flow	of	blood	is	related	to	the	fourth	power	of	the	radius. Thus,	a
reduction	of	seven	percent	is	approximately	related	to	a	30%	greater
blood	flow,	although	it	is	not	possible	to	obtain	by	calculation	a	more
precise	determination	of	this	number. 45
. Personal	communication	with	Dr.	Esselstyn,	9/15/03. 46
. Ornish	D,	Brown	SE,	Scherwitz	LW,	et	al. “Can	lifestyle	changes	reverse
coronary	heart	disease?”	
Lancet
	336	(1990):	129–133. 47
. Ratliff	NB. “Of	rice,	grain,	and	zeal:	lessons	from	Drs. Kempner	and
Esselstyn.”	
Cleveland	Clin. J.	Med
. 67	(2000):	565–566. 48
. American	Heart	Association. “AHA	Dietary	Guidelines. Revision	2000:
A	Statement	for	Healthcare	Professionals	from	the	Nutrition	Committee
of	the	American	Heart	Association.”	
Circulation
	102	(2000):	2296–
2311. 49
. National	Cholesterol	Education	Program. “Third	report	of	the	National
Cholesterol	Education	Program	(NCEP)	expert	panel	on	detection,
evaluation	and	treatment	of	high	blood	cholesterol	in	adult	(adult
treatment	panel	III):	executive	summary.”	Bethesda,	MD:	National
Institutes	of	Health,	2001. 50
. Castelli	W.	“Take	this	letter	to	your	doctor.”	
Prevention
	48	(1996):	61–
64. 51
. Schuler	G,	Hambrecht	R,	Schlierf	G,	et	al. “Regular	physical	exercise
and	low-fat	diet.”	
Circulation
	86	(1992):	1–11.Chapter	6
1
. Flegal	KM,	Carroll	MD,	Ogden	CL,	et	al. “Prevalence	and	trends	in
obesity	among	U.S.	adults,	1999–2000.”	
JAMA
	288	(2002):	1723–1727. 2
. Ogden	CL,	Flegal	KM,	Carroll	MD,	et	al. “Prevalence	and	trends	in
overweight	among	U.S.	children	and	adolescents.”	JAMA	288	(2002):
1728–1732. 3
. Dietz	WH. “Health	consequences	of	obesity	in	youth:	childhood
predictors	of	adult	disease.”	
Pediatrics
	101	(1998):	518–525. 4
. Fontaine	KR,	and	Barofsky	I. “Obesity	and	health-related	quality	of
life.”	
Obesity	Rev. 2	(2001):	173–182. 5
. Colditz	GA.	“Economic	costs	of	obesity	and	inactivity.”	
Med. Sci. Sports
Exerc
. 31	(1999):	S663-S667. 6
. Adcox	S.	“New	state	law	seeks	to	cut	down	obesity.”	
Ithaca	Journal
Sept.	21,	2002:	5A. 7
. Ellis	FR,	and	Montegriffo	VME. “Veganism,	clinical	findings	and
investigations.”	
Am. J.	Clin. Nutr. 23	(1970):	249–255. 8
. Berenson,	G.,	Srinivasan,	S.,	Bao,	W.,	Newman,	W.	P.	r.,	Tracy,	R.	E.,
and	Wattigney	W.	A. “Association	between	multiple	cardiovascular	risk
factors	and	atherosclerosis	to	children	and	young	adults. The	Bogalusa
Heart	Study.”	
New	Engl. J.	Med
.,	338:	1650–1656,	1998. 9
. Key	TJ,	Fraser	GE,	Thorogood	M,	et	al. “Mortality	in	vegetarians	and
nonvegetarians:	detailed	findings	from	a	collaborative	analysis	of	5
prospective	studies.”	
Am. J.	Clin. Nutri. 70(Suppl.) (1999):	516S-524S. 10
. Bergan	JG,	and	Brown	PT. “Nutritional	status	of	“new”	vegetarians.”	
J. Am. Diet. Assoc
. 76	(1980):	151–155. 11
. Appleby	PN,	Thorogood	M,	Mann	J,	et	al. “Low	body	mass	index	in
non-meat	eaters:	the	possible	roles	of	animal	fat,	dietary	fibre,	and
alcohol.”	
Int	J.	Obes
. 22	(1998):	454–460. 12
. Dwyer	JT. “Health	aspects	of	vegetarian	diets.”	
Am. J.	Clin. Nutr. 48
(1988):	712–738. 13
. Key	TJ,	and	Davey	G.	“Prevalence	of	obesity	is	low	in	people	who	do
not	eat	meat.”	
Brit. Med. Journ
. 313	(1996):	816–817. 14
. Shintani	TT,	Hughes	CK,	Beckham	S,	et	al. “Obesity	and	cardiovascular
risk	intervention	through	the	ad	libitum	feeding	of	traditional	Hawaiian
diet.”	
Am. J.	Clin. Nutr. 53	(1991):	1647S–1651S. 15
. Barnard	RJ. “Effects	of	life-style	modification	on	serum	lipids.”	
Arch. Intern. Med
. 151	(1991):	1389–1394. 16
. McDougall	J,	Litzau	K,	Haver	E,	et	al. “Rapid	reduction	of	serumcholesterol	and	blood	pressure	by	a	twelve-day	very	low	fat,	strictly
vegetarian	diet.”	
J. Am. Coll. Nutr. 14	(1995):	491–496. 17
. Ornish	D,	Scherwitz	LW,	Doody	RS,	et	al. “Effects	of	stress
management	training	and	dietary	changes	in	treating	ischemic	heart
disease.”	
JAMA
	249	(1983):	54–59. 18
. Shintani	TT,	Beckham	S,	Brown	AC,	et	al. “The	Hawaii	diet:	ad	libitum
high	carbohydrate,	low	fat	multi-cultural	diet	for	the	reduction	of	chronic
disease	risk	factors:	obesity,	hypertension,	hypercholesterolemia,	and
hyperglycemia.”	
Hawaii	Med. Journ
. 60	(2001):	69–73. 19
. Nicholson	AS,	Sklar	M,	Barnard	ND,	et	al. “Toward	improved
management	of	NIDDM:	a	randomized,	controlled,	pilot	intervention
using	a	lowfat,	vegetarian	diet.”	
Prev. Med
. 29	(1999):	87–91. 20
. Ornish	D,	Scherwitz	LW,	Billings	JH,	et	al. “Intensive	lifestyle	changes
for	reversal	of	coronary	heart	disease.”	
JAMA
	280	(1998):	2001–2007. 21
. Astrup	A,	Toubro	S,	Raben	A,	et	al. “The	role	of	low-fat	diets	and	fat
substitutes	in	body	weight	management:	what	have	we	learned	from
clinical	studies?”	
J. Am. Diet
. Assoc. 97(sup-pl)	(1997):	S82-S87. 22
. Duncan	KH,	Bacon	JA,	and	Weinsier	RL. “The	effects	of	high	and	low
energy	density	diets	on	satiety,	energy	intake,	and	eating	time	of	obese
and	nonobese	subjects.”	
Am. J.	Clin. Nutr. 37	(1983):	763–767. 23
. Heaton	KW. “Food	fibre	as	an	obstacle	to	energy	intake.”	
Lancet
	(1973):
1418–1421. 24
. Levin	N,	Rattan	J,	and	Gilat	T.	“Energy	intake	and	body	weight	in	ovo-
lacto	vegetarians.”	
J.	Clin. Gastroenterol
. 8	(1986):	451–453. 25
. Campbell	TC. “Energy	balance:	interpretation	of	data	from	rural	China.”
Toxicological	Sciences
	52	(1999):	87–94. 26
. Poehlman	ET,	Arciero	PJ,	Melby	CL,	et	al. “Resting	metabolic	rate	and
postprandial	thermogenesis	in	vegetarians	and	nonvegetarians.”	
Am. J.
Clin. Nutr. 48	(1988):	209–213. 27
. The	study	by	Poehlman	et	al. showed	high	oxygen	consumption	and
higher	resting	metabolic	rate	but	was	badly	misinterpreted	by	the
authors. We	had	very	similar	results	with	experimental	rats. 28
. Fogelholm	M,	and	Kukkonen-Harjula	K.	“Does	physical	activity	prevent
weight	gain—a	systematic	review.”	
Obesity	Rev
. 1	(2000):	95–111. 29
. Ravussin	E,	Lillioja	S,	Anderson	TE,	et	al. “Determinants	of	24-hour
energy	expenditure	in	man. Methods	and	results	using	a	respiratory
chamber.”	
J.	Clin. Invest
. 78	(1986):	1568–1578. 30
. Thorburn	AW,	and	Proietto	J. “Biological	determinants	of	spontaneous
physical	activity.”	
Obesity	Rev
. 1	(2000):	87–94. 31
. Krieger	E,	Youngman	LD,	and	Campbell	TC. “The	modulation	ofaflatoxin(AFBl)	induced	preneoplastic	lesions	by	dietary	protein	and
voluntary	exercise	in	Fischer	344	rats.”	
FASEB	J. 2	(1988):	3304	Abs. 32
. Heshka	S,	and	Allison	DB. “Is	obesity	a	disease?”	
Int. J.	Obesity	Rel. Dis
. 25	(2001):	1401–1404. 33
. Kopelman	PG,	and	Finer	N.	“Reply:	is	obesity	a	disease?”	
Int	J.	Obes
. 25	(2001):	1405–1406. 34
. Campbell	TC. “Are	your	genes	hazardous	to	your	health?”	
Nutrition
Advocate
	1	(1995):	1–2,	8. 35
. Campbell	TC. “Genetic	seeds	of	disease. How	to	beat	the	odds.”
Nutrition	Advocate
	1	(1995):	1–2,	8. 36
. Campbell	TC. “The	‘Fat	Gene’	dream	machine.”	
Nutrition	Advocate
	2
(1996):	1–2.Chapter	7
1
. Mokdad	AH,	Ford	ES,	Bowman	BA,	et	al. “Diabetes	trends	in	the	U.S.:
1990–1998.”	
Diabetes
	Care	23	(2000):	1278–1283. 2
. Centers	for	Disease	Control	and	Prevention. “National	Diabetes	Fact
Sheet:	General	Information	and	National	Estimates	on	Diabetes	in	the
United	States,	2000.”	Atlanta,	GA:	Centers	for	Disease	Control	and
Prevention. 3
. Griffin	KL. “New	lifestyles:	new	lifestyles,	hope	for	kids	with	diabetes.”
Milwaukee	Journal	Sentinel
	22	July	2002:	1G. 4
. American	Diabetes	Association. “Type	2	diabetes	in	children	and
adolescents.”	
Diabetes	Care
	23	(2000):	381–389. 5
. Himsworth	HP. “Diet	and	the	incidence	of	diabetes	mellitus.”	
Clin. Sci. 2
(1935):	117–148. 6
. West	KM,	and	Kalbfleisch	JM. “Glucose	tolerance,	nutrition,	and
diabetes	in	Uruguay,	Venezuela,	Malaya,	and	East	Pakistan.”	
Diabetes
15	(1966):	9–18. 7
. West	KM,	and	Kalbfleisch	JM. “Influence	of	nutritional	factors	on
prevalence	of	diabetes.”	
Diabetes
	20	(1971):	99–108. 8
. Fraser	GE. “Associations	between	diet	and	cancer,	ischemic	heart
disease,	and	all-cause	mortality	in	non-Hispanic	white	California
Seventh-day	Adventists.”	
Am. J.	Clin. Nutr. 70(Suppl.) (1999):	532S-
538S. 9
. Snowdon	DA,	and	Phillips	RL. “Does	a	vegetarian	diet	reduce	the
occurrence	of	diabetes?”	
Am. J.	Publ. Health
	75	(1985):	507–512. 10
. Tsunehara	CH,	Leonetti	DL,	and	Fujimoto	WY. “Diet	of	second
generation	Japanese-American	men	with	and	without	non-insulin-
dependent	diabetes.”	
Am. J.	Clin. Nutri. 52	(1990):	731–738. 11
. Marshall	J,	Hamman	RF,	and	Baxter	J. “High-fat,	low-carbohydrate	diet
and	the	etiology	of	non-insulin-dependent	diabetes	mellitus:	the	San	Luis
Valley	Study.”	
Am. J.	Epidemiol
. 134	(1991):	590–603. 12
. Kittagawa	T,	Owada	M,	Urakami	T,	et	al. “Increased	incidence	of	non-
insulin-dependent	diabetes	mellitus	among	Japanese	schoolchildren
correlates	with	an	increased	intake	of	animal	protein	and	fat.”	
Clin. Pediatr
. 37	(1998):	111–116. 13
. Trowell	H.	“Diabetes	mellitus	death-rates	in	England	and	Wales	1920–
1970	and	food	supplies.”	
Lancet
	2	(1974):	998–1002. 14
. Meyer	KA,	Kushi	LH,	Jacobs	DR,	Jr.,	et	al. “Carbohydrates,	dietary
fiber,	and	incident	Type	2	diabetes	in	older	women.”	
Am. J.	Clin. Nutri.71	(2000):	921–930. 15
. Anderson	JW. “Dietary	fiber	in	nutrition	management	of	diabetes.”	In:
G.	Vahouny	V.	and	D.	Kritchevsky	(eds. ),	
Dietary	Fiber:	Basic	and
Clinical	Aspects
,	pp. 343–360. New	York:	Plenum	Press,	1986. 16
. Anderson	JW,	Chen	WL,	and	Sieling	B. “Hypolipidemic	effects	of	high-
carbohydrate,	high-fiber	diets.”	
Metabolism
	29	(1980):	551–558. 17
. Story	L,	Anderson	JW,	Chen	WL,	et	al. “Adherence	to	high-
carbohydrate,	high-fiber	diets:	long-term	studies	of	non-obese	diabetic
men.”	
Journ. Am. Diet. Assoc. 85	(1985):	1105–1110. 18
. Barnard	RJ,	Lattimore	L,	Holly	RG,	et	al. “Response	of	non-insulin-
dependent	diabetic	patients	to	an	intensive	program	of	diet	and	exercise.”
Diabetes	Care
	5	(1982):	370–374. 19
. Barnard	RJ,	Massey	MR,	Cherny	S,	et	al. “Long-term	use	of	a	high-
complex-carbohydrate,	high-fiber,	low-fat	diet	and	exercise	in	the
treatment	of	NIDDM	patients.”	
Diabetes	Care
	6	(1983):	268–273. 20
. Anderson	JW,	Gustafson	NJ,	Bryant	CA,	et	al. “Dietary	fiber	and
diabetes:	a	comprehensive	review	and	practical	application.”	
J. Am. Diet. Assoc
. 87	(1987):	1189–1197. 21
. Jenkins	DJA,	Wolever	TMS,	Bacon	S,	et	al. “Diabetic	diets:	high
carbohydrate	combined	with	high	fiber.”	
Am. J.	Clin. Nutri. 33	(1980):
1729–1733. 22
. Diabetes	Prevention	Program	Research	Group. “Reduction	in	the
incidence	of	Type	2	diabetes	with	lifestyle	intervention	or	Metformin.”
New	Engl. J.	Med
. 346	(2002):	393–403. 23
. Tuomilehto	J,	Lindstrom	J,	Eriksson	JG,	et	al. “Prevention	of	Type	2
diabetes	mellitus	by	changes	in	lifestyle	among	subjects	with	impaired
glucose	tolerance.”	
New	Engl. J.	Med
. 344	(2001):	1343–1350.Chapter	8
1
. Estrogen	present	in	its	free,	unbound	form. 2
. Estrogen	activity	is	due	to	more	than	one	analogue,	but	usually	refers	to
estradiol. I	will	use	the	general	term	“estrogen”	to	include	all	steroid	and
related	female	hormones	whose	effects	parallel	estradiol	activity. A	small
amount	of	testosterone	in	women	also	shows	the	same	effect. 3
. Wu	AH,	Pike	MC,	and	Stram	DO. “Meta-analysis:	dietary	fat	intake,
serum	estrogen	levels,	and	the	risk	of	breast	cancer.”	
J.	Nat. Cancer	Inst
. 91	(1999):	529–534. 4
. Bernstein	L,	and	Ross	RK. “Endogenous	hormones	and	breast	cancer
risk.”	
Epidemiol. Revs. 15	(1993):	48–65. 5
. Pike	MC,	Spicer	DV,	Dahmoush	L,	et	al. “Estrogens,	progestogens,
normal	breast	cell	proliferation,	and	breast	cancer	risk.”	
Epidemiol. Revs. 15	(1993):	17–35. 6
. Bocchinfuso	WP,	Lindzey	JK,	Hewitt	SC,	et	al. “Induction	of	mammary
gland	development	in	estrogen	receptor-alpha	knockout	mice.”
Endocrinology
	141	(2000):	2982–2994. 7
. Atwood	CS,	Hovey	RC,	Glover	JP,	et	al. “Progesterone	induces	side-
branching	of	the	ductal	epithelium	in	the	mammary	glands	of
peripubertal	mice.”	
J.	Endocrinol
. 167	(2000):	39–52. 8
. Rose	DP,	and	Pruitt	BT. “Plasma	prolactin	levels	in	patients	with	breast
cancer.”	
Cancer
	48	(1981):	2687–2691. 9
. Dorgan	JF,	Longcope	C,	Stephenson	HE,	Jr.,	et	al. “Relation	of
prediagnostic	serum	estrogen	and	androgen	levels	to	breast	cancer	risk.”
Cancer	Epidemiol	Biomarkers	Prev
	5	(1996):	533–539. 10
. Dorgan	JF,	Stanczyk	FZ,	Longcope	C,	et	al. “Relationship	of	serum
dehydroepiandrosterone	(DHEA),	DHEA	sulfate,	and	5-androstene-3
beta,	17	beta-diol	to	risk	of	breast	cancer	in	postmenopausal	women.”
Cancer	Epidemiol	Biomarkers	Prev
	6	(1997):
11
. Thomas	HV,	Key	TJ,	Allen	DS,	et	al. “A	prospective	study	of
endogenous	serum	hormone	concentrations	and	breast	cancer	risk	in
post-menopausal	women	on	the	island	of	Guernsey.”	
Brit. J. Cancer
	76
(1997):	410–405. 12
. Hankinson	SE,	Willett	W,	Manson	JE,	et	al. “Plasma	sex	steroid
hormone	levels	and	risk	of	breast	cancer	in	postmenopausal	women.”	
J.
Nat. Cancer	Inst
. 90	(1998):	1292–1299. 13
. Rosenthal	MB,	Barnard	RJ,	Rose	DP,	et	al. “Effects	of	a	high-complex-
carbohydrate,	low-fat,	low-cholesterol	diet	on	levels	of	serum	lipids	andestradiol.”	
Am. J.	Med
. 78	(1985):	23–27. 14
. Adlercreutz	H.	“Western	diet	and	Western	diseases:	some	hormonal	and
biochemical	mechanisms	and	associations.”	
Scand. J.	Clin. Lab. Invest
. 50(Suppl.201)	(1990):	3–23. 15
. Heber	D,	Ashley	JM,	Leaf	DA,	et	al. “Reduction	of	serum	estradiol	in
postmenopausal	women	given	free	access	to	low-fat	high-carbohydrate
diet.”	
Nutrition
	7	(1991):	137-139. 16
. Rose	DP,	Goldman	M,	Connolly	JM,	et	al. “High-fiber	diet	reduces
serum	estrogen	concentrations	in	premenopausal	women.”	
Am. J.	Clin. Nutr. 54	(1991):	520-525. 17
. Rose	DP,	Lubin	M,	and	Connolly	JM. “Efects	of	diet	supplementation
with	wheat	bran	on	serum	estrogen	levels	in	the	follicular	and	luteal
phases	of	the	menstrual	cycle.”	
Nutrition
	13	(1997):	535-539. 18
. Tymchuk	CN,	Tessler	SB,	and	Barnard	RJ. “Changes	in	sex	hormone-
binding	globulin,	insulin,	and	serum	lipids	in	postmenopausal	women	on
a	low-fat,	high-fiber	diet	combined	with	exercise.”	
Nutr. Cancer
	38
(2000):	158-162. 19
. Key	TJA,	Chen	J,	Wang	DY,	et	al. “Sex	hormones	in	women	in	rural
China	and	in	Britain.”	
Brit. J. Cancer
	62	(1990):	631-636. 20
. Prentice	R,	Thompson	D,	Clifford	C,	et	al. “Dietary	fat	reduction	and
plasma	estradiol	concentration	in	healthy	postmenopausal	women.”	
J.
Natl. Cancer	Inst. 82	(1990):	129-134. 21
. Boyar	AP,	Rose	DP,	and	Wynder	EL. “Recommendations	for	the
prevention	of	chronic	disease:	the	application	for	breast	disease.”	
Am. J.
Clin. Nutr. 48(3	Suppl)	
(1988):	896-900. 22
. Nandi	S,	Guzman	RC,	and	Yang	J. “Hormones	and	mammary
carcinogenesis	in	mice,	rats	and	humans:	a	unifying	hypothesis.”	
Proc. National	Acad. Sci
	92	(1995):	3650-3657. 23
. Peto	J,	Easton	DF,	Matthews	FE,	et	al. “Cancer	mortality	in	relatives	of
women	with	breast	cancer,	the	OPCS	study.”	
Int. J. Cancer
	65	(1996):
275-283. 24
. Colditz	GA,	Willett	W,	Hunter	DJ,	et	al. “Family	history,	age,	and	risk	of
breast	cancer. Prospective	data	from	the	Nurses’	Health	Study.”	
JAMA
270	(1993):	338-343. 25
. National	Human	Genome	Research	Institute. “Learning	About	Breast
Cancer.”	Accessed	at	
http://www.genome.gov/10000507#ql
26
. Futreal	PA,	Liu	Q,	Shattuck-Eidens	D,	et	al. “BRCA1	mutations	in
primary	breast	and	ovarian	carcinomas.”	
Science
	266	(1994):	120-122. 27
. Miki	Y,	Swensen	J,	Shatttuck-Eidens	D,	et	al. “A	strong	candidate	for	the
breast	and	ovarian	cancer	susceptibility	gene	BRCA1.”	
Science
	266(1994):	66-71. 28
. Wooster	R,	Bignell	G,	Lancaster	J,	et	al. “Identification	of	the	breast
cancer	susceptibility	gene	BRCA2.”	
Nature
	378	(1995):	789-792. 29
. Tavtigian	SV,	Simard	J,	Rommens	J,	et	al. “The	complete	BRCA2	gene
and	mutations	in	chromosome	13q-linked	kindreds.”	
Nat. Genet. 12
(1996):	333-337. 30
. Ford	D,	Easton	D,	Bishop	DT,	et	al. “Risks	of	cancer	in	BRCA1
mutation	carriers.”	
Lancet
	343	(1994):	692-695. 31
. Antoniou	A,	Pharoah	PDP,	Narod	S,	et	al. “Average	risks	of	breast	and
ovarian	cancer	associated	with	BRCA1	or	BRCA2	mutations	detected	in
case	series	unselected	for	family	history:	a	combined	analysis	of	22
studies.”	
Am. J.	Hum. Genet. 72	(2003):	1117-1130. 32
. Newman	B,	Mu	H,	Butler	LM,	et	al. “Frequency	of	breast	cancer
attributable	to	BRCA1	in	a	population-based	series	of	American
women.”	
JAMA
	279	(1998):	915-921. 33
. Peto	J,	Collins	N,	Barfoot	R,	et	al. “Prevalence	of	BRCA1	and	BRCA2
gene	mutations	in	patients	with	early-onset	breast	cancer.”	
J.	Nat. Cancer	Inst. 91	(1999):	943-949. 34
. Tabar	L,	Fagerberg	G,	Chen	HH,	et	al. “Efficacy	of	breast	cancer
screening	by	age. New	results	from	the	Swedish	Two-County	Trial.”
Cancer
	75	(1995):	2507-2517. 35
. Bjurstram	N,	Bjorneld	L,	Duffy	SW,	et	al. “The	Gothenburg	Breast
Cancer	Screening	Trial:	first	results	on	mortality,	incidence,	and	mode	of
detection	for	women	ages	39-49	years	at	randomization.”	
Cancer
	80
(1997):	2091-2099. 36
. Frisell	J,	Lidbrink	E,	Hellstrom	L,	et	al. “Follow-up	after	11	years:
update	of	mortality	results	in	the	Stockholm	mammographic	screening
trial.”	
Breast	Cancer	Res. Treat	1997
	45	(1997):	263-270. 37
. Greenlee	RT,	Hill-Harmon	MB,	Murray	T,	et	al. “Cancer	statistics,
2001.”	
CA	Cancer	J.	Clin. 51	(2001):	15-36. 38
. Cairns	J. “The	treatment	of	diseases	and	the	War	against	Cancer.”	
Sci. Am. 253	(1985):	31-39. 39
. Cuzick	J,	and	Baum	M.	“Tamoxifen	and	contralateral	breast	cancer.”
Lancet
	2	(1985):	282. 40
. Cuzick	J,	Wang	DY,	and	Bulbrook	RD. “The	prevention	of	breast
cancer.”	
Lancet
	1	(1986):	83-86. 41
. Fisher	B,	Costantino	JP,	Wickerham	DL,	et	al. “Tamoxifen	for
prevention	of	breast	cancer:	report	of	the	National	Surgical	Adjuvant
Breast	and	Bowel	Project	P-1	Study.”	
J.	Nat. Cancer	Inst. 90	(1998):
1371-1388.42
. Freedman	AN,	Graubard	BI,	Rao	SR,	et	al. “Estimates	of	the	number	of
U.S.	women	who	could	benefit	from	tamoxifen	for	breast	cancer
chemoprevention.”	
J.	Nat. Cancer	Inst. 95	(2003):	526-532. 43
. Powles	T,	Eeles	R,	Ashley	S,	et	al. “Interim	analysis	of	the	incidence	of
breast	cancer	in	the	Royal	Marsden	Hospital	tamoxifen	randomised
chemoprevention	trial.”	
Lancet
	352	(1998):	98-101. 44
. Veronesi	U,	Maisonneuve	P,	Costa	A,	et	al. “Prevention	of	breast	cancer
with	tamoxifen:	preliminary	findings	from	the	Italian	randomised	trial
among	hysterectomised	women.”	
Lancet
	352	(1998):	93-97. 45
. Cuzick	J. “A	brief	review	of	the	current	breast	cancer	prevention	trials
and	proposals	for	future	trials.”	
Eur	J	Cancer
	36	(2000):	1298-1302. 46
. Cummings	SR,	Eckert	S,	Krueger	KA,	et	al. “The	effect	of	raloxifene	on
risk	of	breast	cancer	in	postmenopausal	women:	results	from	the	MORE
randomized	trial.”	
JAMA
	281	(1999):	2189-2197. 47
. Dorgan	JF,	Hunsberger	S,	A.,	McMahon	RP,	et	al. “Diet	and	sex
hormones	in	girls:	findings	from	a	randomized	controlled	clinical	trial.”
J.	Nat. Cancer	Inst. 95	(2003):	132-141. 48
. Ornish	D,	Scherwitz	LW,	Billings	JH,	et	al. “Intensive	lifestyle	changes
for	reversal	of	coronary	heart	disease.”	
JAMA
	280	(1998):	2001-2007. 49
. Esselstyn	CB,	Ellis	SG,	Medendorp	SV,	et	al. “A	strategy	to	arrest	and
reverse	coronary	artery	disease:	a	5-year	longitudinal	study	of	a	single
physician’s	practice.”	
J. Family	Practice
	41	(1995):	560-568. 50
. Hildenbrand	GLG,	Hildenbrand	LC,	Bradford	K,	et	al. “Five-year
survival	rates	of	melanoma	patients	treated	by	diet	therapy	after	the
manner	of	Gerson:	a	retrospective	review.”	
Alternative	Therapies	in
Health	and	Medicine
	1	(1995):	29-37. 51
. Youngman	LD,	and	Campbell	TC. “Inhibition	of	aflatoxin	Bl-induced
gamma-glutamyl	transpeptidase	positive	(GGT+)	hepatic	preneoplastic
foci	and	tumors	by	low	protein	diets:	evidence	that	altered	GGT+	foci
indicate	neoplastic	potential.”	
Carcinogenesis
	13	(1992):	1607-1613. 52
. Ronai	Z,	Gradia	S,	El-Bayoumy	K,	et	al. “Contrasting	incidence	of	ras
mutations	in	rat	mammary	and	mouse	skin	tumors	induced	by	anti-
benzo[c]phenanthrene-3,4-diol-l,2-epoxide.”	
Carcinogensis
	15	(1994):
2113–2116. 53
. Jeffy	BD,	Schultz	EU,	Selmin	O,	et	al. “Inhibition	of	BRCA-1
expression	by	benzo[a]pyrene	and	diol	epoxide.”	
Mol. Carcinogenesis
26	(1999):	100-118. 54
. Gammon	MD,	Santella	RM,	Neugut	AI,	et	al. “Environmental	toxins	and
breast	cancer	on	Long	Island. I.	Polycyclic	aromatic	hydrocarbon	DNA
adducts.”	
Cancer	Epidemiol	Biomarkers	Prev
	11	(2002):	677-685.55
. Gammon	MD,	Wolff	MS,	Neugut	AI,	et	al. “Environmental	toxins	and
breast	cancer	on	Long	Island. II. Organchlorine	compound	levels	in
blood.”	
Cancer	Epidemiol	Biomarkers	Prey
	11	(2002):	686-697. 56
. Humphries	KH,	and	Gill	S.	“Risks	and	benefits	of	hormone	replacement
therapy:	the	evidence	speaks.”	
Canadian	Med. Assoc. Journ. 168	(2003):
1001-1010. 57
. Writing	Group	for	the	Women’s	Health	Initiative	Investigators. “Risks
and	benefits	of	estrogen	plus	progestin	in	healthy	postmenopausal
women:	principal	results	from	the	Women’s	Health	Initiative
Randomized	Controlled	Trial.”	
JAMA
	288	(2002):	321-333. 58
. Hulley	S,	Grady	D,	Bush	T,	et	al. “Randomized	trial	of	estrogen	plus
progestin	for	secondary	prevention	of	coronary	heart	disease	in
postmenopausal	women. Heart	and	Estrogen/progestin	Replacement
Study	(HERS)	Research	Group.”	
JAMA
	280	(1998):	605-613. 59
. While	this	finding	is	not	statistically	significant,	its	consistency	with	the
WHI	finding	is	striking. 60
. International	Agency	for	Cancer	Research. “Globocan”	(accessed	18
October	2002),	
http://www-dep.iarc/globocan.html
.”
61
. Kinzler	KW,	and	Vogelstein	B. “Lessons	from	Heredity. Colorectal
Cancer.”	
Cell
	87	(1996):	159-170. 62
. Ferlay	J,	Bray	F,	Pisani	P,	et	al. GLOBOCAN	2000:	Cancer	Incidence,
mortality	and	prevalence	worldwide,	Version	1.0. Lyon,	France:
IARCPress,	2001. 63
. Limited	version	of	Ferlay	et	al. document	available	at
http://www.dep.iarc.fr/globocan/globocan.htm
,	last	updated	on
03/02/2001. 64
. Expert	Panel. Food,	nutrition	and	the	prevention	of	cancer,	a	global
perspective. Washington,	DC:	American	Institute	for	Cancer
Research/World	Cancer	Research	Fund,	1997. 65
. Armstrong	D,	and	Doll	R.	“Environmental	factors	and	cancer	incidence
and	mortality	in	different	countries,	with	special	reference	to	dietary
practices.”	
Int. J. Cancer
	15	(1975):	617-631. 66
. Burkitt	DP. “Epidemiology	of	cancer	of	the	colon	and	the	rectum.”
Cancer
	28	(1971):	3-13. 67
. Jansen	MCJF,	Bueno-de-Mesquita	HB,	Buzina	R,	et	al. “Dietary	fiber
and	plant	foods	in	relation	to	colorectal	cancer	mortality:	The	Seven
Countries	Study.”	
Int. J. Cancer
	81	(1999):	174-179. 68
. Whiteley	LO,	and	Klurfeld	DM. “Are	dietary	fiber-induced	alterations	in
colonic	epithelial	cell	proliferation	predictive	of	fiber’s	effect	on	colon
cancer?”	
Nutr. Cancer
	36	(2000):	131–149.69
. Most	of	these	associations	were	not	statistically	significant,	but	the
consistency	of	the	inverse	association	between	fiber	and	colorectal
cancer	was	impressive. 70
. Campbell	TC,	Wang	G,	Chen	J,	et	al. “Dietary	fiber	intake	and	colon
cancer	mortality	in	The	People’s	Republic	of	China.”	
In:
	D.	Kritchevsky
C.	Bonfield	and	J.	W.	Anderson	(eds. ),	
Dietary	Fiber
,	pp. 473–480. New
York,	NY:	Plenum	Publishing	Corporation,	1990. 71
. Trock	B,	Lanza	E,	and	Greenwald	P.	“Dietary	fiber,	vegetables,	and
colon	cancer:	critical	review	and	meta-analysis	of	the	epidemiologic
evidence.”	
J.	Nat. Cancer	Inst. 82	(1990):	650-661. 72
. Howe	GR,	Benito	E,	Castelleto	R,	et	al. “Dietary	intake	of	fiber	and
decreased	risk	of	cancers	of	the	colon	and	rectum:	evidence	from	the
combined	analysis	of	13	case-control	studies.”	
J.	Nat. Cancer	Inst. 84
(1992):	1887-1896. 73
. Bingham	SA,	Day	NE,	Luben	R,	et	al. “Dietary	fibre	in	food	and
protection	against	colorectal	cancer	in	the	European	Prospective
Investigation	into	Cancer	and	Nutrition	(EPIC):	an	observational	study.”
Lancet
	361	(2003):	1496-1501. 74
. O’Keefe	SJD,	Ndaba	N,	and	Woodward	A. “Relationship	between
nutritional	status,	dietary	intake	patterns	and	plasma	lipoprotein
concentrations	in	rural	black	South	Africans.”	
Hum. Nutr. Clin. Nutr. 39
(1985):	335-341. 75
. Sitas	F.	“Histologically	diagnosed	cancers	in	South	Africa,	1988.”	
S.
African	Med. J. 84	(1994):	344-348. 76
. O’Keefe	SJD,	Kidd	M,	Espitalier-Noel	G,	et	al. “Rarity	of	colon	cancer
in	Africans	is	associated	with	low	animal	product	consumption,	not
fiber.”	
Am. J.	Gastroenterology
	94	(1999):	1373-1380. 77
. McKeown-Eyssen	G.	“Epidemiology	of	colorectal	cancer	revisited:	are
serum	triglycerides	
and/or	plasma	glucose	associated	with	risk?”	
Cancer
Epidemiol	Biomarkers	Prev
	3	(1994):	687-695. 78
. Giovannucci	E.	“Insulin	and	colon	cancer.”	
Cancer	Causes	and	Control
6	(1995):	164-179. 79
. Bruce	WR,	Giacca	A,	and	Medline	A. “Possible	mechanisms	relating
diet	and	risk	of	colon	cancer.”	
Cancer	Epidemiol	Biomarkers	Prev
	9
(2000):	1271-1279. 80
. Kono	S,	Honjo	S,	Todoroki	I,	et	al. “Glucose	intolerance	and	adenomas
of	the	sigmoid	colon	in	Japanese	men	(Japan).”	
Cancer	Causes	and
Control
	9	(1998):	441-446. 81
. Schoen	RE,	Tangen	CM,	Kuller	LH,	et	al. “Increased	blood	glucose	and
insulin,	body	size,	and	incident	colorectal	cancer.”	
J.	Nat. Cancer	Inst.91	(1999):	1147-1154. 82
. Bruce	WR,	Wolever	TMS,	and	Giacca	A. “Mechanisms	linking	diet	and
colorectal	cancer:	the	possible	role	of	insulin	resistance.”	
Nutr. Cancer
37	(2000):	19-26. 83
. Lipkin	M,	and	Newmark	H.	“Development	of	clinical	chemoprevention
trials.”	
J.	Nat. Cancer	Inst. 87	(1995):	1275-1277. 84
. Holt	PR,	Atillasoy	EO,	Gilman	J,	et	al. “Modulation	of	abnormal	colonic
epithelial	cell	proliferation	and	differentiation	by	low-fat	dairy	foods. A
randomized	trial.”	
JAMA
	280	(1998):	1074-1079. 85
. Mobarhan	S.	“Calcium	and	the	colon:	recent	findings.”	
Nutr. Revs. 57
(1999):	124-126. 86
. Alberts	DS,	Ritenbuagh	C,	Story	JA,	et	al. “Randomized,	double-
blinded,	placebo-controlled	study	of	effect	of	wheat	bran	fiber	and
calcium	on	fecal	bile	acids	in	patients	with	resected	adenomatous	colon
polyps.”	
J.	Nat. Cancer	Inst. 88	(1996):	81-92. 87
. Chen	J,	Campbell	TC,	Li	J,	et	al. Diet,	
life-style	and	mortality	in	China. A	study	of	the	characteristics	of	65	Chinese	counties. Oxford,	UK;
Ithaca,	NY;	Beijing,	PRC:	Oxford	University	Press;	Cornell	University
Press;	People’s	Medical	Publishing	House,	1990. 88
. Jass	JR.	“Colon	cancer:	the	shape	of	things	to	come.”	
Gut
	45	(1999):
794-795. 89
. Burt	RW. “Colon	cancer	screening.”	
Gastroenterology
	119	(2000):	837–
853. 90
. Winawer	SJ,	Zauber	AG,	Ho	MN,	et	al. “Prevention	of	colorectal	cancer
by	colonoscopic	polypectomy.”	
New	Engl. J.	Med. 329	(1993):	1977-
1981. 91
. Pignone	M,	Rich	M,	Teutsch	SM,	et	al. “Screening	for	colorectal	cancer
in	adults	at	average	risk:	a	summary	of	the	evidence	for	the	U.S.
Preventive	Services	Task	Force.”	
Ann. Internal	Med. 137	(2002):	132-
141. 92
. Scott	RJ,	and	Sobol	HH. “Prognostic	implications	of	cancer
susceptibility	genes:	Any	news?”	
Recent	Results	in	Cancer	Research
	151
(1999):	71-84. 93
. Lee	ML,	Wang	R-T,	Hsing	AW,	et	al. “Case-control	study	of	diet	and
prostate	cancer	in	China.”	
Cancer	Causes	and	Control
	9	(1998):	545-
552. 94
. Villers	A,	Soulie	M,	Haillot	O,	et	al. “Prostate	cancer	screening	(III):	risk
factors,	natural	history,	course	without	treatment.”	
Progr. Urol. 7	(1997):
655-661. 95
. Stanford	JL. “Prostate	cancer	trends	1973-1995.”	Bethesda,	MD:	SEERProgram,	National	Cancer	Institute,	1998. 96
. Chan	JM,	and	Giovannucci	EL. “Dairy	products,	calcium,	and	vitamin	D
and	risk	of	prostate	cancer.”	
Epidemiol. Revs. 23	(2001):	87-92. 97
. Giovannucci	E.	“Dietary	influences	of	1,25	(OH)
2
	vitamin	D	in	relation
to	prostate	cancer:	a	hypothesis.”	
Cancer	Causes	and	Control
	9	(1998):
567-582. 98
. Chan	JM,	Stampfer	MJ,	Ma	J,	et	al. “Insulin-like	growth	factor-I	(IGF-I)
and	IGF	binding	protein-3	as	predictors	of	advanced-stage	prostate
cancer.”	
J	Natl	Cancer	Inst
	94	(2002):	1099-1109. 99
. Doi	SQ,	Rasaiah	S,	Tack	I,	et	al. “Low-protein	diet	suppresses	serum
insulin-like	growth	factor-1	and	decelerates	the	progresseion	of	growth
hormone-induced	glomerulosclerosis.”	
Am. J.	Nephrol. 21	(2001):	331-
339. 100
. Heaney	RP,	McCarron	DA,	Dawson-Hughes	B,	et	al. “Dietary	changes
favorably	affect	bond	remodeling	in	older	adults.”	
J. Am. Diet. Assoc. 99
(1999):	1228-1233. 101
. Allen	NE,	Appleby	PN,	Davey	GK,	et	al. “Hormones	and	diet:	low
insulin-like	growth	factor-I	but	normal	bioavailable	androgens	in	vegan
men.”	
Brit. J. Cancer
	83	(2000):	95-97. 102
. Cohen	P,	Peehl	DM,	and	Rosenfeld	RG. “The	IGF	axis	in	the	prostate.”
Horm. Metab. res. 26	(1994):	81-84.Chapter	9
1
. Mackay	IR. “Tolerance	and	immunity.”	
Brit. Med. Journ. 321	(2000):
93-96. 2
. Jacobson	DL,	Gange	SJ,	Rose	NR,	et	al. “Short	analytical	review. Epidemiology	and	estimated	population	burden	of	selected	autoimmune
diseases	in	the	United	States.”	
Clin. Immunol. Immunopath. 84	(1997):
223-243. 3
. Davidson	A,	and	Diamond	B. “Autoimmune	diseases.”	
New	Engl. J.
Med. 345	(2001):	340-350. 4
. Aranda	R,	Sydora	BC,	McAllister	PL,	et	al. “Analysis	of	intestinal
lymphocytes	in	mouse	colitis	mediated	by	transfer	of	CD4*,
CD45RB
high
	T	cells	to	SCID	recipients.”	
J.	Immunol. 158	(1997):	3464-
3473. 5
. Folgar	S,	Gatto	EM,	Raina	G,	et	al. “Parkinsonism	as	a	manifestation	of
multiple	sclerosis.”	
Movement	Disorders
	18	(2003):	108-113. 6
. Cantorna	MT. “Vitamin	D	and	autoimmunity:	is	vitamin	D	status	an
environmental	factor	affecting	autoimmune	disease	prevalence?”	
Proc. Soc. Exp. Biol. Med. 223	(2000):	230-233. 7
. DeLuca	HF,	and	Cantorna	MT. “Vitamin	D:	its	role	and	uses	in
immunology.”	
FASEB	J. 15	(2001):	2579-2585. 8
. Winer	S,	Astsaturov	I,	Cheung	RK,	et	al. “T	cells	of	multiple	sclerosis
patients	target	a	common	environmental	peptide	that	causes	encephalitis
in	mice.”	
J.	Immunol. 166	(2001):	4751-4756. 9
. Davenport	CB. “Multiple	sclerosis	from	the	standpoint	of	geographic
distribution	and	race.”	
Arch. Neurol. Pschiatry
	8	(1922):	51-58. 10
. Alter	M,	Yamoor	M,	and	Harshe	M.	“Multiple	sclerosis	and	nutrition.”
Arch. Neurol. 31	(1974):	267-272. 11
. Carroll	M.	“Innate	immunity	in	the	etiopathology	of	autoimmunity.”
Nature	Immunol. 2	(2001):	1089-1090. 12
. Karjalainen	J,	Martin	JM,	Knip	M,	et	al. “A	bovine	albumin	peptide	as	a
possible	trigger	of	insulin-dependent	Diabetes	Mellitus.”	
New	Engl. Journ. Med. 327	(1992):	302-307. 13
. Akerblom	HK,	and	Knip	M.	“Putative	environmental	factors	and	Type	1
diabetes.”	
Diabetes/Metabolism	Revs. 14	(1998):	31-67. 14
. Naik	RG,	and	Palmer	JP	“Preservation	of	beta-cell	function	in	Type	1
diabetes.”	
Diabetes	Rev. 7	(1999):	154-182. 15
. Virtanen	SM,	Rasanen	L,	Aro	A,	et	al. “Infant	feeding	in	Finnish
children	less	than	7	yr	of	age	with	newly	diagnosed	IDDM. Childhooddiabetes	in	Finland	Study	Group.”	
Diabetes	Care
	14	(1991):	415-417. 16
. Savilahti	E,	Akerblom	HK,	Tainio	V-M,	et	al. “Children	with	newly
diagnosed	insulin	dependent	diabetes	mellitus	have	increased	levels	of
cow’s	milk	antibodies.”	
Diabetes	Res. 7	(1988):	137-140. 17
. Yakota	A,	Yamaguchi	T,	Ueda	T,	et	al. “Comparison	of	islet	cell
antibodies,	islet	cell	surfact	antibodies	and	anti-bovine	serum	albumin
antibodies	in	Type	1	diabetes.”	
Diabetes	Res. Clin. Pract. 9	(1990):	211-
217. 18
. Hammond-McKibben	D,	and	Dosch	H-M.	“Cow’s	milk,	bovine	serum
albumin,	and	IDDM:	can	we	settle	the	controversies?”	
Diabetes	Care
	20
(1997):	897-901. 19
. Akerblom	HK,	Vaarala	O,	Hyoty	H,	et	al. “Environmental	factors	in	the
etiology	of	Type	1	diabetes.”	
Am. J.	Med. Genet. (
Semin. Med. Genet.
) 115	(2002):	18-29. 20
. Gottlieb	MS,	and	Root	HE	“Diabetes	mellitus	in	twins.”	
Diabetes
	17
(1968):	693-704. 21
. Barnett	AH,	Eff	C,	Leslie	RDG,	et	al. “Diabetes	in	identical	twins:	a
study	of	200	pairs.”	
Diabetologia
	20	(1981):	87-93. 22
. Borch-Johnsen	K,	Joner	G,	Mandrup-Poulsen	T,	et	al. “Relation	between
breast	feeding	and	incidence	rates	of	insulin-dependent	diabetes	mellitus:
a	hypothesis.”	
Lancet
	2	(1984):	1083-1086. 23
. Perez-Bravo	F,	Carrasco	E,	Gutierrez-Lopez	MD,	et	al. “Genetic
predisposition	and	environmental	factors	leading	to	the	development	of
insulin-dependent	diabetes	mellitus	in	Chilean	children.”	
J.	Mol. Med. 74
(1996):	105-109. 24
. Kostraba	JN,	Cruickshanks	KJ,	Lawler-Heavner	J,	et	al. “Early	exposure
to	cow’s	milk	and	solid	foods	in	infancy	genetic	predisposition,	and	risk
of	IDDM.”	
Diabetes
	42	(1993):	288-295. 25
. Pyke	DA. “The	genetic	perspective:	putting	research	into	practice.”	
In:
Diabetes	1988,	Amsterdam,	1989,	pp. 1227-1230. 26
. Kaprio	J,	Tuomilehto	J,	Koskenvuo	M,	et	al. “Concordance	for	Type	1
(insulin-dependent)	and	Type	2	(non-insulin-dependent)	diabetes
mellitus	in	a	population-based	cohort	of	twins	in	Finland.”	
Diabetologia
35	(1992):	1060-1067. 27
. Dahl-Jorgensen	K,	Joner	G,	and	Hanssen	KF. “Relationship	between
cow’s	milk	consumption	and	incidence	of	IDDM	in	childhood.”
Diabetes	Care
	14	(1991):	1081-1083. 28
. The	proportion	of	Type	1	diabetes	due	to	the	consumption	of	cow’s	milk,
the	r2	value,	is	96%. 29
. LaPorte	RE,	Tajima	N,	Akerblom	HK,	et	al. “Geographic	differences	inthe	risk	of	insulin-dependent	diabetes	mellitus:	the	importance	of
registries.”	
Diabetes	Care
	8(Suppl. 1)	(1985):	101-107. 30
. Bodansky	HJ,	Staines	A,	Stephenson	C,	et	al.
_OceanofPDF.com_The_China_Study__The_Most_Comprehensive_St_-_T_Colin_Campbell.txt
Summarize the following text section accurately and concisely. Maintain specific details and numerical information, and use anti-repetition mechanisms:

        “Assessment	of	a	modified	household	food
weighing	method	in	a	study	of	bone	health	in	China. ”	
European	J. Clin. Nutr. 48	(1994):	442–452. 28. Potischman	N,	McCulloch	CE,	Byers	T,	et	al. “Breast	cancer	and	dietary
and	plasma	concentrations	of	carotenoids	and	vitamin	A. ”	
Am. J.
Assessment of a modified household food weighing method in a study of bone health in China.
What is the topic of the study mentioned in the first few lines of the text?
Potischman N, McCulloch CE, Byers T, et al.
Who are the authors of the article "Breast cancer and dietary and plasma concentrations of carotenoids and vitamin A"?
Diet, lifestyle, and mortality in China. A study of the characteristics of 65 Chinese counties.
What is the title of the article by Campbell TC and Chen J?
International Agency for Research on Cancer
What is the name of the organization mentioned in the passage that published a report on carcinogens?
Chittenden RH
Who is the author of the article "The nutrition of man"?